An International, Multicentric, Prospective, Observational Study to Evaluate Monosyn® Suture Material for Anastomoses in the Gastrointestinal Tract (PROMEGAT)

June 29, 2018 updated by: Aesculap AG

An International, Multicentric, Prospective, Observational Study to Evaluate Monosyn® Suture Material for Anastomoses in the Gastrointestinal Tract.

The aim of this non-interventional study is to evaluate the efficacy of a monofilament, mid-term absorbable suture material (Monosyn®) for anastomosis performed in the gastrointestinal tract using the frequency of anastomosis leakage as a primary parameter.

Postoperative complication rate, length of hospital stay, costs, time to perform the anastomosis and handling will serve as secondary endpoints.

The question is addressed, whether a monofilament suture material is as effective as a braided suture material for anastomosis construction within the gastrointestinal tract.

Study Overview

Study Type

Observational

Enrollment (Actual)

106

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Gangnam-Gu, Seoul, Korea, Republic of, 135-72
        • Gangnam Severance Hospital
      • Gyeonggi-do, Korea, Republic of, 463-707
        • Seoul National University Bundang Hospital
      • Kuala Lumpur, Malaysia, 59100
        • University Malaya Medical Centre
      • Manila, Philippines
        • Philippine General Hospital
      • Taipei City, Taiwan, 112 Beitou District
        • Veterans General Hospital-Taipei

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

adult patients

Description

Inclusion Criteria:

  • Age 18 years and older
  • ASA I-III
  • Indication for an elective tumor surgery within the GI tract (stomach, small intestine, large intestine)
  • Written informed consent

Exclusion Criteria:

  • Emergency surgery
  • Peritonitis
  • Patients undergoing an operation due to a tumour within the pancreas, rectum, esophagus
  • Pregnant women and breast-feeding women
  • Chemotherapy
  • Current immunosuppressive therapy
  • Radiotherapy on the treated region within the last 2 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Monosyn
Construction of a gastrointestinal anastomoses
Monosyn will be used to perform the gastrointestinal anastomoses

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of anastomosis leakage rate
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 7 days
Anastomotic leak is defined as radiographic demonstration of a fistula or non-absorbable material drainage from a wound after oral administration, or visible disruption of the suture line during re-exploration.
participants will be followed for the duration of hospital stay, an expected average of 7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative complication rate
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 7 days
As postoperative complications the following parameter will be documented: peritonitis, wound infection, bleeding, abscess, fistula, perforation, obstipation and stenosis. Wound infections, peritonitis and abscess are defined according to the Centres for Disease Control and Prevention (CDC, 17).
participants will be followed for the duration of hospital stay, an expected average of 7 days
Reoperation rate
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 7 days
participants will be followed for the duration of hospital stay, an expected average of 7 days
Length of hospital stay
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 10 days
Duration from day of operation until the day of discharge from the hospital.
participants will be followed for the duration of hospital stay, an expected average of 10 days
Stay in the intensive care unit
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 7 days
Duration from the first day in the ICU until the last day in the ICU. In the case of readmission to the ICU the sum of all days within the ICU.
participants will be followed for the duration of hospital stay, an expected average of 7 days
Duration to perform the anastomosis
Time Frame: intraoperatively
The time recorded for the construction of the anastomosis begins with the placement of the first stitch and ends with cutting the excess material from the last stitch.
intraoperatively
Cost
Time Frame: duration of the intervention (approximately 18 months)

Calculation of the cost of material is based on the actual hospital costs for the suture material and the number of used threads by the surgeon.

For the calculation of the operation costs, the time to perform the anastomosis will be multiplied with the cost of one operation minute (50-100 €).

duration of the intervention (approximately 18 months)
Handling of the device
Time Frame: End of the Study (approximately 18 months)

Intra-operative handling of the suture material will be reported on a separate document one time per participating surgeon at the end of the study. The following criteria will be assessed:

knot security, knot pull tensile strength, knot run-down, tissue drag, elasticity and feeling of the suture material. For the rating a 5-point scale is used

End of the Study (approximately 18 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2014

Primary Completion (ACTUAL)

June 1, 2016

Study Completion (ACTUAL)

June 1, 2016

Study Registration Dates

First Submitted

March 5, 2014

First Submitted That Met QC Criteria

March 5, 2014

First Posted (ESTIMATE)

March 6, 2014

Study Record Updates

Last Update Posted (ACTUAL)

July 2, 2018

Last Update Submitted That Met QC Criteria

June 29, 2018

Last Verified

June 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gastrointestinal Neoplasms

Clinical Trials on Monosyn

3
Subscribe